Mark Lebwohl
Mount Sinai School of Medicine
New York
NY 10029
USA
Name/email consistency: high
- Calcitriol ointment 3 microg/g is safe and effective over 52 weeks for the treatment of mild to moderate plaque psoriasis. Lebwohl, M., Ortonne, J.P., Andres, P., Briantais, P. Cutis (2009)
- New roles for systemic retinoids. Lebwohl, M., Kathryn, M. J. Drugs. Dermatol (2006)
- Psoriasis treatment: traditional therapy. Lebwohl, M., Ting, P.T., Koo, J.Y. Ann. Rheum. Dis. (2005)
- A clinician's paradigm in the treatment of psoriasis. Lebwohl, M. J. Am. Acad. Dermatol. (2005)
- No evidence for increased risk of cutaneous squamous cell carcinoma in patients with rheumatoid arthritis receiving etanercept for up to 5 years. Lebwohl, M., Blum, R., Berkowitz, E., Kim, D., Zitnik, R., Osteen, C., Wallis, W.J. Arch. Dermatol (2005)
- Proven efficacy of tacrolimus for facial and intertriginous psoriasis. Lebwohl, M., Freeman, A., Chapman, M.S., Feldman, S., Hartle, J., Henning, A. Arch. Dermatol (2005)
- Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials. Lebwohl, M., Dinehart, S., Whiting, D., Lee, P.K., Tawfik, N., Jorizzo, J., Lee, J.H., Fox, T.L. J. Am. Acad. Dermatol. (2004)
- Innovations in the treatment of psoriasis. Lebwohl, M. J. Am. Acad. Dermatol. (2004)
- An international, randomized, double-blind, placebo-controlled phase 3 trial of intramuscular alefacept in patients with chronic plaque psoriasis. Lebwohl, M., Christophers, E., Langley, R., Ortonne, J.P., Roberts, J., Griffiths, C.E. Arch. Dermatol (2003)
- Topical calcitriol is degraded by ultraviolet light. Lebwohl, M., Quijije, J., Gilliard, J., Rollin, T., Watts, O. J. Invest. Dermatol. (2003)